| RS2508834923 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS2508834962 |
NF1
|
Health Risk |
Pathogenic |
Cardiovascular phenotype, Hereditary cancer-predisposing syndrome |
| RS2508835058 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS2508835122 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS2508835198 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS2508835216 |
NF1
|
Health Risk |
Pathogenic |
Cardiovascular phenotype, Hereditary cancer-predisposing syndrome |
| RS2508835380 |
NF1
|
Health Risk |
Pathogenic |
Cardiovascular phenotype, Hereditary cancer-predisposing syndrome |
| RS2508835538 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS2508835559 |
NF1
|
Health Risk |
Pathogenic |
Cardiovascular phenotype, Hereditary cancer-predisposing syndrome |
| RS2508835674 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS2508835680 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS2508837771 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS2508837920 |
NF1
|
Health Risk |
Pathogenic |
— |
| RS2508838042 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS2508840137 |
EFTUD2
|
Health Risk |
Likely pathogenic |
— |
| RS2508840177 |
EFTUD2
|
Health Risk |
Pathogenic |
Global developmental delay, Global developmental delay |
| RS2508840210 |
EFTUD2
|
Health Risk |
Likely pathogenic |
Mandibulofacial dysostosis-microcephaly syndrome, Mandibulofacial dysostosis-microcephaly syndrome |
| RS2508842735 |
NF1
|
Health Risk |
Pathogenic/Likely pathogenic |
Juvenile myelomonocytic leukemia, Neurofibromatosis |
| RS2508866762 |
EFTUD2
|
Health Risk |
Pathogenic |
Mandibulofacial dysostosis-microcephaly syndrome, Mandibulofacial dysostosis-microcephaly syndrome |
| RS2508877889 |
FANCI
|
Health Risk |
Pathogenic |
Fanconi anemia, Fanconi anemia |
| RS2508878334 |
FANCI
|
Health Risk |
Pathogenic |
Fanconi anemia, Fanconi anemia |
| RS2508879017 |
FANCI
|
Health Risk |
Likely pathogenic |
Fanconi anemia complementation group I, Fanconi anemia complementation group I |
| RS2508896569 |
DNAAF19
|
Health Risk |
Likely pathogenic |
Primary ciliary dyskinesia 17, Primary ciliary dyskinesia 17 |
| RS2508900110 |
DNAAF19
|
Health Risk |
Pathogenic |
Primary ciliary dyskinesia, Primary ciliary dyskinesia |
| RS2508900227 |
DNAAF19
|
Health Risk |
Pathogenic |
Primary ciliary dyskinesia, Primary ciliary dyskinesia |
| RS2508900598 |
DNAAF19
|
Health Risk |
Pathogenic |
Primary ciliary dyskinesia, Primary ciliary dyskinesia |
| RS2508918698 |
IMPG2
|
Health Risk |
Likely pathogenic |
Retinal dystrophy, Retinal dystrophy |
| RS2508923016 |
GFAP
|
Health Risk |
Likely pathogenic |
— |
| RS2508925248 |
IMPG2
|
Health Risk |
Pathogenic |
— |
| RS2508925411 |
IMPG2
|
Health Risk |
Pathogenic |
Retinal dystrophy, Retinal dystrophy |
| RS2508925531 |
IMPG2
|
Health Risk |
Likely pathogenic |
Vitelliform macular dystrophy 5, Retinal dystrophy |
| RS2508933141 |
GFAP
|
Health Risk |
Conflicting classifications of pathogenicity |
Alexander disease, Alexander disease |
| RS2508933747 |
GFAP
|
Health Risk |
Likely pathogenic |
— |
| RS2508935534 |
ITGA3
|
Health Risk |
Pathogenic |
Epidermolysis bullosa, junctional 7 |
| RS2508937834 |
ITGA3
|
Health Risk |
Likely pathogenic |
— |
| RS2508940444 |
GFAP
|
Health Risk |
Likely pathogenic |
— |
| RS2508942846 |
IMPG2
|
Health Risk |
Pathogenic |
— |
| RS2508943991 |
IMPG2
|
Health Risk |
Pathogenic |
— |
| RS2508947210 |
IMPG2
|
Health Risk |
Pathogenic |
— |
| RS2508947333 |
IMPG2
|
Health Risk |
Pathogenic |
— |
| RS2508948888 |
GFAP
|
Health Risk |
Likely pathogenic |
Alexander disease, Alexander disease |
| RS2508949801 |
GFAP
|
Health Risk |
Likely pathogenic |
Alexander disease, Alexander disease |
| RS2508949861 |
GFAP
|
Health Risk |
Likely pathogenic |
— |
| RS2508951149 |
GFAP
|
Health Risk |
Pathogenic |
GFAP-related disorder, GFAP-related disorder |
| RS2508969338 |
IMPG2
|
Health Risk |
Pathogenic |
— |
| RS2508986019 |
IMPG2
|
Health Risk |
Likely pathogenic |
— |
| RS2508989619 |
IMPG2
|
Health Risk |
Likely pathogenic |
— |
| RS2508989693 |
IMPG2
|
Health Risk |
Pathogenic/Likely pathogenic |
Cone-rod dystrophy, Cone-rod dystrophy |
| RS2508996470 |
IMPG2
|
Health Risk |
Pathogenic |
— |
| RS2509016110 |
FANCI
|
Health Risk |
Likely pathogenic |
Fanconi anemia complementation group I, Fanconi anemia complementation group I |
| RS2509016412 |
FANCI
|
Health Risk |
Likely pathogenic |
Fanconi anemia complementation group I, Fanconi anemia complementation group I |
| RS2509022419 |
IMPG2
|
Health Risk |
Likely pathogenic |
— |
| RS2509043231 |
IMPG2
|
Health Risk |
Likely pathogenic |
Vitelliform macular dystrophy 3, Vitelliform macular dystrophy 3 |
| RS2509062269 |
IMPG2
|
Health Risk |
Likely pathogenic |
— |
| RS2509062500 |
IMPG2
|
Health Risk |
Pathogenic |
— |
| RS2509062524 |
IMPG2
|
Health Risk |
Pathogenic |
Retinal dystrophy, Retinal dystrophy |
| RS2509062717 |
IMPG2
|
Health Risk |
Likely pathogenic |
Retinal dystrophy, Retinal dystrophy |
| RS2509063453 |
IMPG2
|
Health Risk |
Pathogenic/Likely pathogenic |
IMPG2-related recessive retinopathy, IMPG2-related recessive retinopathy |
| RS2509077600 |
FANCI
|
Health Risk |
Likely pathogenic |
Fanconi anemia complementation group I, Fanconi anemia complementation group I |
| RS2509113878 |
SGCA
|
Health Risk |
Pathogenic/Likely pathogenic |
Autosomal recessive limb-girdle muscular dystrophy, Autosomal recessive limb-girdle muscular dystrophy type 2D |
| RS2509113935 |
SGCA
|
Health Risk |
Likely pathogenic |
Autosomal recessive limb-girdle muscular dystrophy type 2D, Autosomal recessive limb-girdle muscular dystrophy type 2D |
| RS2509113948 |
SGCA
|
Health Risk |
Pathogenic |
Autosomal recessive limb-girdle muscular dystrophy type 2D, Autosomal recessive limb-girdle muscular dystrophy type 2D |
| RS2509117878 |
SGCA
|
Health Risk |
Likely pathogenic |
Autosomal recessive limb-girdle muscular dystrophy type 2D, Autosomal recessive limb-girdle muscular dystrophy type 2D |
| RS2509117896 |
SGCA
|
Health Risk |
Likely pathogenic |
Autosomal recessive limb-girdle muscular dystrophy type 2D, Autosomal recessive limb-girdle muscular dystrophy type 2D |
| RS2509117897 |
STAT3
|
Health Risk |
Pathogenic |
Hyper-IgE recurrent infection syndrome 1, autosomal dominant |
| RS2509117903 |
SGCA
|
Health Risk |
Likely pathogenic |
Autosomal recessive limb-girdle muscular dystrophy, Autosomal recessive limb-girdle muscular dystrophy |
| RS2509118076 |
SGCA
|
Health Risk |
Likely pathogenic |
Autosomal recessive limb-girdle muscular dystrophy type 2D, Autosomal recessive limb-girdle muscular dystrophy type 2D |
| RS2509118207 |
SGCA
|
Health Risk |
Likely pathogenic |
Autosomal recessive limb-girdle muscular dystrophy type 2D, Autosomal recessive limb-girdle muscular dystrophy type 2D |
| RS2509118228 |
STAT3
|
Health Risk |
Likely pathogenic |
STAT3 gain of function, Hyper-IgE recurrent infection syndrome 1 |
| RS2509118693 |
SGCA
|
Health Risk |
Likely pathogenic |
Autosomal recessive limb-girdle muscular dystrophy type 2D, Autosomal recessive limb-girdle muscular dystrophy type 2D |
| RS2509118765 |
SGCA
|
Health Risk |
Likely pathogenic |
Autosomal recessive limb-girdle muscular dystrophy type 2D, Autosomal recessive limb-girdle muscular dystrophy type 2D |
| RS2509118810 |
SGCA
|
Health Risk |
Pathogenic |
Autosomal recessive limb-girdle muscular dystrophy type 2D, Autosomal recessive limb-girdle muscular dystrophy type 2D |
| RS2509118949 |
SGCA
|
Health Risk |
Pathogenic |
Autosomal recessive limb-girdle muscular dystrophy type 2D, Autosomal recessive limb-girdle muscular dystrophy type 2D |
| RS2509119030 |
SGCA
|
Health Risk |
Likely pathogenic |
Autosomal recessive limb-girdle muscular dystrophy type 2D, Autosomal recessive limb-girdle muscular dystrophy type 2D |
| RS2509119198 |
SGCA
|
Health Risk |
Likely pathogenic |
Autosomal recessive limb-girdle muscular dystrophy type 2D, Autosomal recessive limb-girdle muscular dystrophy type 2D |
| RS2509121499 |
SGCA
|
Health Risk |
Likely pathogenic |
Autosomal recessive limb-girdle muscular dystrophy type 2D, Autosomal recessive limb-girdle muscular dystrophy type 2D |
| RS2509121804 |
SGCA
|
Health Risk |
Likely pathogenic |
Autosomal recessive limb-girdle muscular dystrophy type 2D, Autosomal recessive limb-girdle muscular dystrophy type 2D |
| RS2509122225 |
SGCA
|
Health Risk |
Likely pathogenic |
Autosomal recessive limb-girdle muscular dystrophy type 2D, Autosomal recessive limb-girdle muscular dystrophy type 2D |
| RS2509122255 |
SGCA
|
Health Risk |
Likely pathogenic |
Autosomal recessive limb-girdle muscular dystrophy type 2D, Autosomal recessive limb-girdle muscular dystrophy type 2D |
| RS2509122809 |
RAD51D
|
Health Risk |
Pathogenic |
Gastric cancer, Gastric cancer |
| RS2509123048 |
SGCA
|
Health Risk |
Pathogenic/Likely pathogenic |
Autosomal recessive limb-girdle muscular dystrophy type 2D, Autosomal recessive limb-girdle muscular dystrophy type 2D |
| RS2509123275 |
SGCA
|
Health Risk |
Likely pathogenic |
Autosomal recessive limb-girdle muscular dystrophy type 2D, Autosomal recessive limb-girdle muscular dystrophy type 2D |
| RS2509124437 |
RAD51D
|
Health Risk |
Pathogenic |
Gastric cancer, Gastric cancer |
| RS2509124456 |
RAD51D
|
Health Risk |
Likely pathogenic |
Breast-ovarian cancer, familial |
| RS2509124487 |
RAD51D
|
Health Risk |
Likely pathogenic |
Breast-ovarian cancer, familial |
| RS2509124515 |
RAD51D
|
Health Risk |
Likely pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS2509124620 |
RAD51D
|
Health Risk |
Conflicting classifications of pathogenicity |
Breast-ovarian cancer, familial |
| RS2509124625 |
RAD51D
|
Health Risk |
Likely pathogenic |
Breast-ovarian cancer, familial |
| RS2509124779 |
RAD51D
|
Health Risk |
Likely pathogenic |
Breast-ovarian cancer, familial |
| RS2509125000 |
RAD51D
|
Health Risk |
Likely pathogenic |
Breast-ovarian cancer, familial |
| RS2509125153 |
SGCA
|
Health Risk |
Likely pathogenic |
Autosomal recessive limb-girdle muscular dystrophy type 2D, Autosomal recessive limb-girdle muscular dystrophy type 2D |
| RS2509125158 |
RAD51D
|
Health Risk |
Likely pathogenic |
Breast-ovarian cancer, familial |
| RS2509125245 |
SGCA
|
Health Risk |
Likely pathogenic |
Autosomal recessive limb-girdle muscular dystrophy type 2D, Autosomal recessive limb-girdle muscular dystrophy type 2D |
| RS2509125625 |
SGCA
|
Health Risk |
Likely pathogenic |
Autosomal recessive limb-girdle muscular dystrophy type 2D, Autosomal recessive limb-girdle muscular dystrophy type 2D |
| RS2509126902 |
BRIP1
|
Health Risk |
Pathogenic |
Familial cancer of breast, Familial cancer of breast |
| RS2509128875 |
RAD51D
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS2509129015 |
RAD51D
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS2509129209 |
RAD51D
|
Health Risk |
Pathogenic/Likely pathogenic |
Breast-ovarian cancer, familial |
| RS2509130047 |
RAD51D
|
Health Risk |
Likely pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS2509130113 |
RAD51D
|
Health Risk |
Likely pathogenic |
Breast-ovarian cancer, familial |